Search research articles
Contact Us
Filters
Showing results (81-90 of 122) with videos related to
Page
of 13
Sort By:
Journal of the American Heart Association
|
May 6, 2026
2025 Acute Coronary Syndrome Guideline: Missing the Boat on <i>CYP2C19</i> Genotyping
Larisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 19, 2019
Frequency and clinical outcomes of CYP2C19 genotype-guided escalation and de-escalation of antiplatelet therapy in a real-world clinical setting
Jesse Martin, Alexis K Williams, Melissa D Klein, et al.
Clinical Pharmacology and Therapeutics
|
July 20, 2024
Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction
Maryam Jamal AlSaeed, Cameron D Thomas, Francesco Franchi, et al.
Circulation. Genomic and Precision Medicine
|
April 5, 2018
Clinical Outcomes and Sustainability of Using <i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
Craig R Lee, Vindhya B Sriramoju, Alexandra Cervantes, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 24, 2011
Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart
Matthew L Edin, Zhongjing Wang, J Alyce Bradbury, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
February 27, 2007
Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways
Shilin Yang, Li Lin, Ji-Xiong Chen, et al.
Pharmacogenetics and Genomics
|
May 3, 2005
Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy
Steven G Terra, Karen K Hamilton, Daniel F Pauly, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 21, 2015
Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer
Gina Song, Teresa K Tarrant, Taylor F White, et al.
JACC. Advances
|
February 4, 2026
Impact of Area-Level Socioeconomic Deprivation on Post-PCI Outcomes Stratified by P2Y<sub>12</sub> Inhibitor Therapy
Jean G Malavé, Cameron D Thomas, Francesco Franchi, et al.
Frontiers in Pharmacology
|
May 17, 2021
Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes
Raju Khatri, John K Fallon, Craig Sykes, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 122) with videos related to
Sort By:
Page
of 13
Journal of the American Heart Association
|
May 6, 2026
2025 Acute Coronary Syndrome Guideline: Missing the Boat on <i>CYP2C19</i> Genotyping
Larisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 19, 2019
Frequency and clinical outcomes of CYP2C19 genotype-guided escalation and de-escalation of antiplatelet therapy in a real-world clinical setting
Jesse Martin, Alexis K Williams, Melissa D Klein, et al.
Clinical Pharmacology and Therapeutics
|
July 20, 2024
Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction
Maryam Jamal AlSaeed, Cameron D Thomas, Francesco Franchi, et al.
Circulation. Genomic and Precision Medicine
|
April 5, 2018
Clinical Outcomes and Sustainability of Using <i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
Craig R Lee, Vindhya B Sriramoju, Alexandra Cervantes, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 24, 2011
Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart
Matthew L Edin, Zhongjing Wang, J Alyce Bradbury, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
February 27, 2007
Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways
Shilin Yang, Li Lin, Ji-Xiong Chen, et al.
Pharmacogenetics and Genomics
|
May 3, 2005
Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy
Steven G Terra, Karen K Hamilton, Daniel F Pauly, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 21, 2015
Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer
Gina Song, Teresa K Tarrant, Taylor F White, et al.
JACC. Advances
|
February 4, 2026
Impact of Area-Level Socioeconomic Deprivation on Post-PCI Outcomes Stratified by P2Y<sub>12</sub> Inhibitor Therapy
Jean G Malavé, Cameron D Thomas, Francesco Franchi, et al.
Frontiers in Pharmacology
|
May 17, 2021
Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes
Raju Khatri, John K Fallon, Craig Sykes, et al.
Page
of 13